Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Am J Pathol ; 2024 Jun 15.
Article in English | MEDLINE | ID: mdl-38885925

ABSTRACT

Local tetanus develops when limited amounts of tetanus neurotoxin (TeNT) are released by Clostridium tetani generated from spores inside a necrotic wound. Within days, a spastic paralysis restricted to the muscles of the affected anatomical area develops. This paralysis follows the retrograde transport of TeNT inside the axons of spinal cord motoneurons and its uptake by inhibitory interneurons with cleavage of a vesicle-associated membrane protein required for neurotransmitter release. Consequently, incontrollable excitation of motoneurons causes contractures of innervated muscles and leads to local spastic paralysis. Here, the initial events occurring close to the site of TeNT release were investigated in a mouse model of local tetanus. A peripheral flaccid paralysis was found to occur, before or overlapping, the spastic paralysis. At variance from the confined TeNT proteolytic activity at the periphery, central vesicle-associated membrane protein cleavage can be detected within inhibitory interneurons controlling motor neuron efferents innervating muscle groups distant from the site of TeNT release. These results indicate that TeNT does have peripheral activity in tetanus and explains why the spastic paralysis observed in local tetanus, although confined to single limbs, generally affects multiple muscles. The initial TeNT neuroparalytic activity can be detected by measuring the compound muscle action potential, providing a very early diagnosis and therapy, and thus preventing the ensuing life-threatening generalized tetanus.

2.
Int J Mol Sci ; 23(8)2022 Apr 14.
Article in English | MEDLINE | ID: mdl-35457172

ABSTRACT

Tetanus and Botulinum type B neurotoxins are bacterial metalloproteases that specifically cleave the vesicle-associated membrane protein VAMP at an identical peptide bond, resulting in inhibition of neuroexocytosis. The minute amounts of these neurotoxins commonly used in experimental animals are not detectable, nor is detection of their VAMP substrate sensitive enough. The immune detection of the cleaved substrate is much more sensitive, as we have previously shown for botulinum neurotoxin type A. Here, we describe the production in rabbit of a polyclonal antibody raised versus a peptide encompassing the 13 residues C-terminal with respect to the neurotoxin cleavage site. The antibody was affinity purified and found to recognize, with high specificity and selectivity, the novel N-terminus of VAMP that becomes exposed after cleavage by tetanus toxin and botulinum toxin type B. This antibody recognizes the neoepitope not only in native and denatured VAMP but also in cultured neurons and in neurons in vivo in neurotoxin-treated mice or rats, suggesting the great potential of this novel tool to elucidate tetanus and botulinum B toxin activity in vivo.


Subject(s)
Botulinum Toxins, Type A , Tetanus , Animals , Antibodies/metabolism , Mice , Neurotoxins/metabolism , Peptides/metabolism , Proteolysis , R-SNARE Proteins/chemistry , R-SNARE Proteins/metabolism , Rabbits , Rats , Tetanus Toxin/chemistry , Tetanus Toxin/metabolism
3.
PLoS Negl Trop Dis ; 18(1): e0011825, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38190386

ABSTRACT

Snake envenoming is a major, but neglected, tropical disease. Among venomous snakes, those inducing neurotoxicity such as kraits (Bungarus genus) cause a potentially lethal peripheral neuroparalysis with respiratory deficit in a large number of people each year. In order to prevent the development of a deadly respiratory paralysis, hospitalization with pulmonary ventilation and use of antivenoms are the primary therapies currently employed. However, hospitals are frequently out of reach for envenomated patients and there is a general consensus that additional, non-expensive treatments, deliverable even long after the snake bite, are needed. Traumatic or toxic degenerations of peripheral motor neurons cause a neuroparalysis that activates a pro-regenerative intercellular signaling program taking place at the neuromuscular junction (NMJ). We recently reported that the intercellular signaling axis melatonin-melatonin receptor 1 (MT1) plays a major role in the recovery of function of the NMJs after degeneration of motor axon terminals caused by massive Ca2+ influx. Here we show that the small chemical MT1 agonists: Ramelteon and Agomelatine, already licensed for the treatment of insomnia and depression, respectively, are strong promoters of the neuroregeneration after paralysis induced by krait venoms in mice, which is also Ca2+ mediated. The venom from a Bungarus species representative of the large class of neurotoxic snakes (including taipans, coral snakes, some Alpine vipers in addition to other kraits) was chosen. The functional recovery of the NMJ was demonstrated using electrophysiological, imaging and lung ventilation detection methods. According to the present results, we propose that Ramelteon and Agomelatine should be tested in human patients bitten by neurotoxic snakes acting presynaptically to promote their recovery of health. Noticeably, these drugs are commercially available, safe, non-expensive, have a long bench life and can be administered long after a snakebite even in places far away from health facilities.


Subject(s)
Antivenins , Indenes , Snake Bites , Humans , Mice , Animals , Antivenins/therapeutic use , Snake Bites/complications , Snake Bites/drug therapy , Receptors, Melatonin/therapeutic use , Snake Venoms , Recovery of Function , Calcium , Snakes , Bungarus
4.
Toxicon ; 52(7): 824-8, 2008 Dec 01.
Article in English | MEDLINE | ID: mdl-18812184

ABSTRACT

Bacillus anthracis secretes two binary toxins: lethal toxin (PA + LF) and edema toxin (PA + EF) that play a major role in the pathogenesis of anthrax. Their activities can synergize or interfere among each other, depending on the cell type. It is therefore fundamental to know their concentration ratio in vivo. Here, we report the first determination of the concentration ratio of anthrax toxin components LF/EF in the serum of rabbits infected with B. anthracis spores.


Subject(s)
Anthrax/microbiology , Antigens, Bacterial/blood , Bacterial Toxins/blood , Animals , Antigens, Bacterial/toxicity , Bacillus anthracis/pathogenicity , Bacterial Toxins/toxicity , Blotting, Western , Linear Models , Rabbits
5.
Sci Rep ; 8(1): 10619, 2018 Jul 13.
Article in English | MEDLINE | ID: mdl-30006575

ABSTRACT

Phospholipases A2 are a major component of snake venoms. Some of them cause severe muscle necrosis through an unknown mechanism. Phospholipid hydrolysis is a possible explanation of their toxic action, but catalytic and toxic properties of PLA2s are not directly connected. In addition, viperid venoms contain PLA2-like proteins, which are very toxic even if they lack catalytic activity due to a critical mutation in position 49. In this work, the PLA2-like Bothrops asper myotoxin-II, conjugated with the fluorophore TAMRA, was found to be internalized in mouse myotubes, and in RAW264.7 cells. Through experiments of protein fishing and mass spectrometry analysis, using biotinylated Mt-II as bait, we found fifteen proteins interacting with the toxin and among them nucleolin, a nucleolar protein present also on cell surface. By means of confocal microscopy, Mt-II and nucleolin were shown to colocalise, at 4 °C, on cell membrane where they form Congo-red sensitive assemblies, while at 37 °C, 20 minutes after the intoxication, they colocalise in intracellular spots going from plasmatic membrane to paranuclear and nuclear area. Finally, nucleolin antagonists were found to inhibit the Mt-II internalization and toxic activity and were used to identify the nucleolin regions involved in the interaction with the toxin.


Subject(s)
Crotalid Venoms/metabolism , Group II Phospholipases A2/metabolism , Neurotoxins/metabolism , Phosphoproteins/metabolism , RNA-Binding Proteins/metabolism , Reptilian Proteins/metabolism , Animals , Bothrops , Cell Membrane/metabolism , Cell Nucleus/metabolism , Crotalid Venoms/toxicity , Group II Phospholipases A2/toxicity , HeLa Cells , Humans , Hydrolysis , Intravital Microscopy , Mice , Microscopy, Confocal , Muscle Fibers, Skeletal , Neurotoxins/toxicity , Phosphoproteins/antagonists & inhibitors , Phosphoproteins/genetics , Primary Cell Culture , Protein Binding/drug effects , Protein Domains , RAW 264.7 Cells , RNA Interference , RNA-Binding Proteins/antagonists & inhibitors , RNA-Binding Proteins/genetics , Reptilian Proteins/toxicity , Nucleolin
6.
Farmaco ; 58(11): 1083-97, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14572859

ABSTRACT

The N-substituted tricyclic 2-aminochromone derivatives 1a, 2a, and 2b were obtained by treating the corresponding (methylthio) or (methylsulfinyl) derivatives 10, 11, or 12, respectively, with an excess of the proper amines. Compound 2c was synthesized through the reaction of 2-naphthol with the ethyl N,N-diphenylmalonamate/POCl(3) reagent 14. The N-substituted 4-aminocoumarin bicyclic and tricyclic derivatives 5-8 were prepared by treating the corresponding chloro derivatives with the excess suitable amines. Compounds 1, 2, 5-8 were tested in vitro for their antiproliferative activity (DNA synthesis inhibition in Ehrlich cells) and cytotoxicity (MTT test in HeLa cells). The inhibitory properties of three selected compounds (5c, 5e, 7c) on protein and RNA syntheses in Ehrlich cells were also evaluated. Among the 27 compounds tested, 10 4-aminocoumarin derivatives (5-8) and two 2-aminochromone derivatives (1a and 2a) showed an appreciable antiproliferative activity (IC(50) range: 1.74-13.8 microM), whereas only four compounds 5-8 exhibited a comparable cytotoxic activity (IC(50) range: 4.95-12.9 microM).


Subject(s)
Chromones/toxicity , Coumarins/toxicity , Growth Inhibitors/toxicity , Pyrans/toxicity , Animals , Carcinoma, Ehrlich Tumor/drug therapy , Chromones/chemistry , Chromones/pharmacology , Coumarins/chemistry , Coumarins/pharmacology , Dose-Response Relationship, Drug , Growth Inhibitors/chemistry , Growth Inhibitors/pharmacology , HeLa Cells , Humans , Mice , Pyrans/chemistry , Pyrans/pharmacology , Xenograft Model Antitumor Assays/methods
7.
Toxicon ; 88: 11-20, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24951874

ABSTRACT

Notexin (Ntx) is a group I phospholipase A2 (PLA2) protein, main component of the Australian snake Notechis scutatus scutatus venom. It is both a presynaptic neurotoxin and a myotoxin. In this work, for the first time, a method for the production and folding of recombinant Ntx was developed. Ntx was produced with wild type sequence (rNtx), with an extra peptide (T7-Ntx) or a methionine (M-Ntx) before Asn-1, and with Asn-1 substituted by alanine (Ntx-A1) or by serine (Ntx-S1). The proteins were analyzed for their catalytic and toxic activities. rNtx activity resulted to be comparable to that of the venom extracted protein. The Ntx N-terminus was found to have a major influence on both the catalytic and toxic activities of the protein. The first amino acid of snake venom PLA2s is highly conserved: it is an asparagine in about all group I PLA2s, while in most (>70%) of group II PLA2s it is a serine or an asparagine. Interestingly, Ntx-S1 resulted to be, for both enzymatic and toxic activities, the mutant most similar to the wild type protein. The role of the catalytic activity of Ntx in its toxicity was investigated by replacing the aspartic acid 49, involved in the coordination of the cofactor calcium ion, by a lysine. The obtained mutant (Ntx-K49) is deprived of catalytic activity but possesses a residual toxicity.


Subject(s)
Elapid Venoms/biosynthesis , Escherichia coli/genetics , Mutation , Protein Folding , Recombinant Proteins/biosynthesis , Amino Acid Sequence , Animals , Catalytic Domain , Elapid Venoms/chemistry , Elapid Venoms/genetics , Elapid Venoms/isolation & purification , Elapid Venoms/toxicity , Mice , Molecular Sequence Data , Phospholipases A2/metabolism , Rats , Rats, Wistar , Recombinant Proteins/isolation & purification
8.
Cell Microbiol ; 9(4): 924-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17087730

ABSTRACT

Pathogenic strains of Bacillus anthracis produce two potent toxins, lethal toxin (LT), a metalloprotease that cleaves mitogen-activated protein kinase kinases, and oedema toxin (ET), a calcium/calmodulin-dependent adenylate cyclase. Emerging evidence indicates a role for both toxins in suppressing the initiation of both innate and adaptive immune responses, which are essential to keep the infection under control. Here we show that LT and ET inhibit chemotaxis of T-cells and macrophages by subverting signalling by both CXC and CC chemokine receptors. The data highlight a novel strategy of immunosuppression by B. anthracis based on inhibition of immune cell homing.


Subject(s)
Antigens, Bacterial/pharmacology , Bacterial Toxins/pharmacology , Chemotaxis/drug effects , Receptors, Chemokine/metabolism , Signal Transduction/drug effects , T-Lymphocytes/drug effects , Bacillus anthracis/metabolism , Cells, Cultured , Chemokine CCL3 , Chemokine CXCL12 , Chemokines, CC/metabolism , Chemokines, CXC/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Flow Cytometry , Humans , Immunoblotting , MAP Kinase Kinase 1/metabolism , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Mitogen-Activated Protein Kinase Kinases/metabolism , Phosphorylation/drug effects , Receptors, Chemokine/physiology , T-Lymphocytes/cytology , T-Lymphocytes/metabolism
9.
Bioorg Med Chem ; 11(7): 1311-8, 2003 Apr 03.
Article in English | MEDLINE | ID: mdl-12628658

ABSTRACT

4-Hydroxymethyl-1,6,8-trimethylfuro[2,3-h]quinolin-2(1H)-one (HOFQ) was prepared by a new profitable way, which allowed to synthesize also 4-methoxymethyl-1,6,8-trimethylfuro[2,3-h]quinolin-2(1H)-one (MOFQ), and 4-hydroxymethyl-6,8-dimethylfuro[2,3-h]quinolin-2(1H)-one (HOHFQ). Some biological activities of the three compounds were studied in comparison with 8-MOP. In the dark, they inhibited topoisomerase II, leading to a moderate antiproliferative activity in mammalian cells. The antiproliferative activity was also tested upon UVA irradiation in mammalian cells: all compounds showed higher activity than 8-MOP, without mutagenicity and skin phototoxicity, with the best results for HOFQ. Photobinding to DNA was investigated, demonstrating a different sequence specificity for these furoquinolinones in comparison with furocoumarins. For all these features, HOFQ and the other analogues appeared very promising photochemotherapeutic agents, whose mechanism of action will be further investigated.


Subject(s)
Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/pharmacology , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , Furans/chemical synthesis , Furans/pharmacology , Quinolones/chemical synthesis , Quinolones/pharmacology , Topoisomerase II Inhibitors , Animals , Antineoplastic Agents/metabolism , Carcinoma, Ehrlich Tumor , Cattle , DNA/metabolism , DNA/radiation effects , Dermatitis, Phototoxic/pathology , Electrophoresis, Polyacrylamide Gel , Enzyme Inhibitors/metabolism , Escherichia coli/drug effects , Escherichia coli/genetics , Guinea Pigs , HeLa Cells , Humans , Indicators and Reagents , Magnetic Resonance Spectroscopy , Mutagens/chemical synthesis , Mutagens/metabolism , Mutagens/pharmacology , Photochemistry , Plasmids/drug effects , Plasmids/genetics , Tumor Cells, Cultured , Ultraviolet Rays
SELECTION OF CITATIONS
SEARCH DETAIL